All In MedTech

FDA Clearance Tracker · P890047

PROVISC(TM)VISCOELASTIC PREPARATION

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Sep 26, 1991 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Sep 26, 1991

Approved

Time to decision

764 days

Received Aug 23, 1989. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P890047
Device name
PROVISC(TM)VISCOELASTIC PREPARATION
Applicant location
Fort Worth, TX
Received
Aug 23, 1989
Decided
Sep 26, 1991
Decision
Approved
Supplements
68 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 886.4275
Specialty
Ophthalmology

Every decision under product code LZP

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LZP. The earliest in FDA's data is P810031, decided Jan 14, 1983.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Alcon Research, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.